A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants
← catalyst calendarSponsored by Pfizer (industry) · PFE — their whole pipeline →.
Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Na · None · Basic science
Enrollment
9actual
Sites
1
Country
Netherlands
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-08-28 | actual | When the study began enrolling |
| Primary completion | 2025-10-08 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-11-07 | actual | The whole study's end, after follow-up |
| First posted | 2025-08-17 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-12-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Healthy Adults
Intervention
- Drug: PF-07104091
Primary outcomes
what the primary-completion date above is the date OFPercentage of Total Radiocarbon (14c) excreted in urine
measured From Predose up to 14 days post dose of period 1 and 2
Percentage of Total Radiocarbon (14c) excreted in feces
measured From Predose up to 14 days post dose of period 1 (and if applicable for Period 2)
Percentage of Total Radiocarbon (14c) excreted in vomitus (if applicable)
measured From Predose up to 14 days post dose of period 1 only
Cumulative Percent Recovery of Total Radiocarbon (14C)
measured From Predose up to 14 days post dose of period 1 only
Percentage of Metabolite Detected in Plasma After Oral Administration of PF-07104091
measured From Predose to 14 days post dose of period 1
Percentage of Metabolite Detected in Urine After Oral Administration of PF-07104091
measured From Predose to 14 days post dose of period 1
Percentage of Metabolite Detected in Feces After Oral Administration of PF-07104091
measured From Predose to 14 days post dose of period 1
Permalink · PFE's whole pipeline · Catalyst calendar · Every registered study · What changed